Westmount Square Surgical Center, Westmount, QC, Canada.
Westmount Square Surgical Center, 1 Westmount Square, Suite 801, Westmount, QC, H3Z2P9, Canada.
Surg Endosc. 2023 Aug;37(8):6452-6463. doi: 10.1007/s00464-023-10134-6. Epub 2023 May 22.
Gastrointestinal anastomoses with classical sutures and/or metal staples have resulted in significant bleeding and leak rates. This multi-site study evaluated the feasibility, safety, and preliminary effectiveness of a novel linear magnetic compression anastomosis device, the Magnet System (MS), to form a side-to-side duodeno-ileostomy (DI) diversion for weight loss and type 2 diabetes (T2D) resolution.
In patients with class II and III obesity (body mass index [BMI, kg/m] ≥ 35.0- ≤ 50.0 with/without T2D [HbA1C > 6.5%]), two linear MS magnets were delivered endoscopically to the duodenum and ileum with laparoscopic assistance and aligned, initiating DI; sleeve gastrectomy (SG) was added. There were no bowel incisions or retained sutures/staples. Fused magnets were expelled naturally. Adverse events (AEs) were graded by Clavien-Dindo Classification (CDC).
Between November 22, 2021 and July 18, 2022, 24 patients (83.3% female, mean ± SEM weight 121.9 ± 3.3 kg, BMI 44.4 ± 0.8) in three centers underwent magnetic DI. Magnets were expelled at a median 48.5 days. Respective mean BMI, total weight loss, and excess weight loss at 6 months (n = 24): 32.0 ± 0.8, 28.1 ± 1.0%, and 66.2 ± 3.4%; at 12 months (n = 5), 29.3 ± 1.5, 34.0 ± 1.4%, and 80.2 ± 6.6%. Group mean respective mean HbA1 and glucose levels dropped to 1.1 ± 0.4% and 24.8 ± 6.6 mg/dL (6 months); 2.0 ± 1.1% and 53.8 ± 6.3 mg/dL (12 months). There were 0 device-related AEs, 3 procedure-related serious AEs. No anastomotic bleeding, leakage, stricture, or mortality.
In a multi-center study, side-to-side Magnet System duodeno-ileostomy with SG in adults with class III obesity appeared feasible, safe, and effective for weight loss and T2D resolution in the short term.
采用经典缝线和/或金属钉缝合的胃肠道吻合术会导致明显的出血和渗漏。这项多中心研究评估了新型线性磁压缩吻合装置——磁系统(MS)在形成侧侧十二指肠-回肠吻合术(DI)以进行减重和 2 型糖尿病(T2D)缓解方面的可行性、安全性和初步有效性。
在 II 类和 III 类肥胖患者(身体质量指数 [BMI,kg/m]≥35.0-≤50.0 伴/不伴 T2D [HbA1C>6.5%])中,使用腹腔镜辅助内镜将两个线性 MS 磁体递送至十二指肠和回肠,并进行对齐,以启动 DI;同时进行袖状胃切除术(SG)。没有进行肠切开或保留缝线/吻合钉。融合磁体自然排出。不良事件(AE)按 Clavien-Dindo 分类(CDC)分级。
2021 年 11 月 22 日至 2022 年 7 月 18 日,三个中心的 24 例患者(83.3%为女性,平均体重±SEM 为 121.9±3.3kg,BMI 为 44.4±0.8)接受了磁 DI 治疗。磁体的中位排出时间为 48.5 天。分别在 6 个月(n=24)和 12 个月(n=5)时的相应平均 BMI、总减重和过量减重为:32.0±0.8、28.1±1.0%和 66.2±3.4%;29.3±1.5、34.0±1.4%和 80.2±6.6%。组平均相应平均 HbA1 和血糖水平分别下降至 1.1±0.4%和 24.8±6.6mg/dL(6 个月);2.0±1.1%和 53.8±6.3mg/dL(12 个月)。无器械相关 AE,3 例与操作相关的严重 AE。无吻合口出血、渗漏、狭窄或死亡。
在一项多中心研究中,成人 III 类肥胖患者采用 MS 进行侧侧十二指肠-回肠吻合术联合 SG 治疗,在短期内显示出可行、安全且有效,可实现减重和 T2D 缓解。